Fortrea Holdings Inc. FTRE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Fortrea Holdings Inc. is a global contract research organization (CRO) providing comprehensive clinical development solutions to biopharmaceutical, biotechnology, and medical device companies worldwide. It specializes in Phase I through IV clinical trial management, clinical pharmacology, pharmacovigilance, regulatory …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees14,000
TickerFTRE
Statistics
Market Cap$1.47B
Revenue (TTM)$2.72B
Net Income-$986.2M
Net Margin-36.2%
EPS$-10.81
P/E522.33
P/S0.59
P/B3.04
EV/EBITDA36.74
ROE-64.5%
Dividend Yield—
Price$15.56
Data: Twelve Data · Revenue = mcap / P/S